Rheumatologist Dr. Mahsa Tehrani discusses strategies to prevent the projected rise in Parkinson's disease prevalence. A promising new stem cell therapy for Parkinson's developed at Memorial Sloan Kettering Cancer Center shows positive results in phase 1 trials.